BridgeMD
New treatment option for Smoking
Official title Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
ClinicalTrials.gov ID: NCT06582693
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare the reach and effectiveness of the Refer2Quit intervention for increasing tobacco use treatment and quit rates among household members who smoke versus a treatment as usual group. This clinical trial also aims to study household member and pediatric patient characteristics that are associated with reach and effectiveness of Refer2Quit.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult Intervention Subject Males or females ages ≥18 years in age
- Self-identify as a current combustible tobacco user
- Have a valid cell phone number Child Intervention Subject Must be a CHOP patient Adult Intervention Subject
You likely can't join if
- \<18 years in age.
- Indicates no combustible tobacco smoking Child Intervention Subject Exclusion Criteria
- Not a CHOP patient Adult Control Subject Inclusion Criteria
- Males or females ages ≥18 years in age
- Self-identify as a current combustible tobacco user
- Have a valid cell phone number Child Control Subject Inclusion Criteria
See the full eligibility criteria
- Adult Intervention Subject Males or females ages ≥18 years in age
- Self-identify as a current combustible tobacco user
- Have a valid cell phone number Child Intervention Subject Must be a CHOP patient Adult Intervention Subject
- \<18 years in age.
- Indicates no combustible tobacco smoking Child Intervention Subject Exclusion Criteria
- Not a CHOP patient Adult Control Subject Inclusion Criteria
- Males or females ages ≥18 years in age
- Self-identify as a current combustible tobacco user
- Have a valid cell phone number Child Control Subject Inclusion Criteria
- Must be a CHOP patient Adult Control Subject Exclusion Criteria
- \<18 years in age.
- Indicates no combustible tobacco smoking Child Control Subject Exclusion Criteria
- Not a CHOP patient
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.